Corcept Therapeutics | CORT - 债务



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 12.17B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


债务 更改 日
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
ANI Pharmaceuticals USD 613.76M 3.28M 2026-03
Ardelyx USD 208.26M 653K 2026-03
Aurora Cannabis CAD 23.86M 76.48M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Canopy Growth CAD 278.71M 19.38M 2026-03
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
J&J USD 54.99B 7.05B 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Merck USD 49.12B 222M 2026-03
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 49.01B 2.02B 2026-06
Novartis USD 47B 14.98B 2026-03
Omeros USD 442.16M 199K 2023-09
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 63.19B 536M 2026-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
TG Therapeutics USD 754.44M 884K 2026-06